Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqing Liang

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Translational Medicine|March 19, 2026
Methylation entropy as a novel dimension in liquid biopsy: enhanced multimodal framework for cancer detection and tissue-of-origin classificationXiaoqiong Jia, Yongjun Li, Baochen Du, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2022
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancerJiannan Chen, Jianhua Hu, Lili Gu, et al.
Frontiers in Immunology|February 5, 2025
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cellsZhao Zhang, Lianfeng Zhao, Tinghui Huang, et al.
ACS Omega|July 3, 2026
Therapeutic Potential of Extracellular Vesicles Derived from Sheep Placenta in the Treatment of Skin DisordersGuiyang He, Ruijie Fan, Jie Zhao, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 28, 2023
Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for gliomaFeng Ji, Luxia Xu, Kaili Long, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumorsJiannan Chen, Wenying Li, Shuai Wang, et al.
Cancer Biology & Therapy|December 9, 2014
Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapyQiaoling Sun, Jinghong Zhou, Zheng Zhang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|December 28, 2020
Phosphatidylinositol 4-kinase β mutations cause nonsyndromic sensorineural deafness and inner ear malformationXiulan Su, Yufei Feng, Sofia A Rahman, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Translational Medicine|March 19, 2026
Methylation entropy as a novel dimension in liquid biopsy: enhanced multimodal framework for cancer detection and tissue-of-origin classificationXiaoqiong Jia, Yongjun Li, Baochen Du, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2022
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancerJiannan Chen, Jianhua Hu, Lili Gu, et al.
Frontiers in Immunology|February 5, 2025
A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cellsZhao Zhang, Lianfeng Zhao, Tinghui Huang, et al.
ACS Omega|July 3, 2026
Therapeutic Potential of Extracellular Vesicles Derived from Sheep Placenta in the Treatment of Skin DisordersGuiyang He, Ruijie Fan, Jie Zhao, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 28, 2023
Rabies virus glycoprotein 29 (RVG29) promotes CAR-T immunotherapy for gliomaFeng Ji, Luxia Xu, Kaili Long, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumorsJiannan Chen, Wenying Li, Shuai Wang, et al.
Cancer Biology & Therapy|December 9, 2014
Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapyQiaoling Sun, Jinghong Zhou, Zheng Zhang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|December 28, 2020
Phosphatidylinositol 4-kinase β mutations cause nonsyndromic sensorineural deafness and inner ear malformationXiulan Su, Yufei Feng, Sofia A Rahman, et al.
Pageof 7